Abstract
Lung cancer is the commonest cause of fatal malignancy worldwide, with over 900 000 deaths per year (1). The incidence is increasing in developing countries, where the rate was once relatively low. In eastern Asia and China, where the control of tobacco advertising and general public awareness is minimal, the mortality rates are higher than the world average. In developed countries the incidence among women has been rising steadily, matching the increased smoking habits of women since the 1950s (2,3). Smoking causes 85–90% of all lung cancers and it is only in countries with high profile anti-smoking lobbies where the incidence is decreasing. In America there has been a fall in the number of smokers, with a subsequent fall in the incidence of lung cancer in men every year for the last 5 years. The incidence among women, however, only began to plateau in the mid 1990s, which is a 10 year lag behind lung cancer rates in men and reflects smoking habits among American women (4).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Pisani P, Parkin DM, Bray F, et al. (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18–29.
Hill C (1998) Trends in tobacco smoking and consequences on health in France. Prev Med 27:514–519.
Devesa SS, Grauman DJ, Blot WJ, et al. (1999) Cancer surveillance series: Changing geographic patterns of lung cancer mortality in the United States, 1950 through 1994. J Natl Cancer Inst 91:1040–1050.
Garfinkel L, Mushinski M (1999) U.S. cancer incidence, mortality and survival: 1973-1996. Stat Bull Metrop Insur Co 80:23–32.
Arai T, Kuroishi T, Saito Y, et al. (1994) tumor doubling time and prognosis in lung cancer patients: Evaluation from chest films and clinical follow-up study. Japanese Lung Cancer Screening Research Group. Jpn J Clin Oncol 24:199–204.
Theros EG (1977) Caldwell Lecture: Varying manifestations of peripheral pulmonary neoplasms: A radiologie-pathologie correlative study. AJR 128:893–914.
Strauss MJ (1974) The growth characteristics of lung cancer and its application to treatment design. Semin Oncol 1:167–174.
Garland LH (1966) The rate of growth and natural duration of primary bronchial cancer. Am J Radiol 96:604–611.
Strauss GM, Dominioni L (1999) Lung cancer screening and the surgical oncologist: the controversy. Surg Oncol Clin North Am 8:372–387.
Henschke CI, McCauley DI, Yankelevitz DF, et al. (1999) Early Lung Cancer Action Project: Overall design and findings from baseline screening. Lancet 354:99–105.
Patel AM, Davila DG, Peters SG (1993) Paraneoplastic syndromes associated with lung cancer. Mayo Clin Proc 68:278–287.
Schiller JH, Jones JC (1993) Paraneoplastic syndromes associated with lung cancer. Curr Opin Oncol 5:335–342.
Kern WH (1988)The diagnostic accuracy of sputum and urine cytology. Acta Cytol 32:651–654.
MacDouggall B, Weinerman B (1992) The value of sputum cytology. J Gen Intern Med 7:11–13.
Sing A, Freudenberg N, Kortsik C, et al. (1997) Comparison of sensitivity of sputum and brush cytology in the diagnosis of lung carcinomas. Acta Cytol 41:399–408.
Khajotia RR, Mohn A, Pokieser L, et al. (1991) Induced sputum and cytological diagnosis of lung cancer. Lancet 338:976–977.
Larscheid RC, Thorpe PE, Scott WJ (1998) Percutaneous transthoracic needle aspiration biopsy: A comprehensive review of its current role in the diagnosis and treatment of lung tumors. Chest 114:704–709.
Odell M J, Reid KR (1999) Does percutaneous fine-needle aspiration biopsy aid in the diagnosis and surgical management of lung masses? Can J Surg 42:297–301.
Sheth S, Hamper UM, Stanley DB, et al. (1999) US guidance for thoracic biopsy: A valuable alternative to CT. Radiology 210:721–726.
Ghaye B, Dondelinger RF, Dewe W (1999) Percutaneous CT-guided lung biopsy: Sequential versus spiral scanning. A randomized prospective study. Eur Radiol 9:1317–1320.
Cox JE, Chiles C, McManus CM, et al. (1999) Transthoracic needle aspiration biopsy: variables that affect risk of pneumothorax. Radiology 212:165–168.
Wyser C, Stulz P, Soler M, et al (1999) Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. Am J Respir Crit Care Med 159:1450–1456.
Batra P, Brown K Steckel RJ, et al. (1988) MR imaging of the thorax: A comparison of axial, coronal and saggital imaging planes. J Comput Assist Tomogr 12:75–78.
Webb WR, Jensen BG, Gamsu G, et al. (1985) Sagittal MR imaging of the chest: Normal and abnormal. J Comput Assist Tomogr 9:471–479.
Webb WR, Gatsonis C, Zerhouni E A, et al. (1991) CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the radiologic diagnostic oncology group. Radiology 178: 705–713.
Glazer GM, Gross BH, Aisen AM, et al. (1985) Imaging of the pulmonary hilum: A prospective comparative study in patients with lung cancer. Am J Radiol 145:245–248.
O’Connell RS, McLoud TC, Wilkin EW (1983) Superior sulcus tumor: Radiographic diagnosis and work up. Am J Radiol 140:25–30.
Castagno AA, Shuman WP (1987) MR imaging in clinically suspected brachial plexus tumor. Am J Radiol 149:1219–1222.
Salvatierra A, Baamonde C, Llamas JM, et al. (1990) Extrathoracic staging of bronchogenic carcinoma. Chest 97:1052–1058.
Heelan RT, Demas BE, Caravelli J, et al. (1989) Superior sulcus tumors. CT MR Imaging Radiol 170:637–641.
Bittner RC, Felix R (1998) Magnetic resonance (MR) imaging of the chest: State-of-the-art. Eur Respir J 11:1392–1404.
Sarinas PS, Chitkara RK, Buadu EO, et al. (1999) Usefulness of positron emission tomography imaging in the management of lung cancer. Curr Opin Pulm Med 5:201–207.
Gdeedo A, Van Schil P, Corthouts B, et al. (1997) Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. Eur Respir J 10:1547–1551.
Mountain CF (1997) Revision in the International System for Staging Lung Cancer. Chest 111:1710–1717.
Saunders M, Dische S, Barrett A, et al. on behalf of the CHART steering committee (1997) Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non small cell lung cancer: A randomised multicentre trial. Lancet 350:161–165.
PORT Meta-analysis Trialists Group (1998) Postoperative radiotherapy on non-small cell lung cancer: Systematic review and metaanalysis of individual patient data from nine randomised controlled trials. Lancet 352:257–263.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag London Limited
About this chapter
Cite this chapter
Wood, M.K., Spiro, S.G. (2001). Carcinoma of the Lung. In: Sperber, M. (eds) Radiologic Diagnosis of Chest Disease. Springer, London. https://doi.org/10.1007/978-1-4471-0693-7_29
Download citation
DOI: https://doi.org/10.1007/978-1-4471-0693-7_29
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1179-5
Online ISBN: 978-1-4471-0693-7
eBook Packages: Springer Book Archive